Cantargia Ab
Cantargia develops antibody based therapies against the target IL1RAP. The two clinical programs are nadunolimab in phase II development for treatment of cancer, and CAN10 in phase I development for autoimmune/inflammatory diseases.
7-day free trial · no credit card
Verified contacts
23
available on Kipplo
LinkedIn employees
31
11 to 50 range
Open roles
—
no listings
Distinct roles
20
indexed titles
Tech stack
0
tools in use
Monthly traffic
77
organic / mo
Sign up free to see all 23 verified contacts at Cantargia Ab
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
23 contacts with verified email or phone · masked until revealed.
- AS
Annika Sanfridson
Project Director · General Business & Management
EmailPhone - SR
Sara Rattik
Project Director · General Business & Management
EmailPhone - AR
Anna-Carin Ryde
Senior Clinical Supply Manager · Healthcare & Human Services
EmailPhone - HL
Henrik Löfvall
Clinical Project Manager - Bioanalysis · Research & Development
EmailPhone - IS
Ida Stenqvist
Senior Data Manager Bioinformatician · Other
EmailPhone - CG
Caitríona Grönberg
Project Manager Preclinical · Other
EmailPhone - JK
Johan Karlsson
Senior Scientist · Science
EmailPhone - NV
Nina Valkama
Executive Assistant · General Business & Management
EmailPhone - PS
Petter Skoog
Senior Scientist · Science
EmailPhone
Showing 9 of 23 verified contacts
Top roles at Cantargia Ab
20 distinct titles indexed · top 10 shown.
- 2project director
- 2senior scientist
- 1()
- 1, -
- 1-,
- 1chief financial officer
- 1chief medical officer
- 1chief scientific officer
- 1clinical project manager - bioanalysis
- 1director clinical development
- +10more titles
Sign up to unlock all 23 contacts at Cantargia Ab
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 23 verified contacts at Cantargia Ab
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.